News
EMA orphan drug designation is awarded to drugs intended to treat rare diseases that are life-threatening or chronically ...
Pharmacovigilance evolves with technology, employing active surveillance to detect drug-related issues and ensure safety in ...
The European Medicines Agency (EMA) has experienced a turbulent few years. Brexit left the agency reeling, as it was forced to move from its base in London and reduce its services whilst ...
Europe's medicines regulator on Monday launched PRIME, a new initiative to help get the most promising new drugs to patients faster. The European Medicines ... The EMA says the scheme will offer ...
The "Liver Fibrosis & NASH/MASH Drugs Market Report 2025-2035" has been added to ResearchAndMarkets.com's offering.World revenue for the Liver Fibrosis & NASH/MASH Drugs Market is set to surpass US$18 ...
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading biotechnology company developing cutting-edge cell therapies ...
BrainStorm Cell Therapeutics Inc. , a leading biotechnology company developing cutting-edge cell therapies for neurodegenerative diseases, today announced the submission of an Investigational New Drug ...
Substandard and fake medicines remain a major threat in Africa, risking lives and fuelling drug resistance. A unified ...
Pheasant Island sits between the borders of France and Spain in the Bidasoa River (Picture: Getty Images) ‘There are no pheasants on Pheasant Island,’ complained the French author Victor Hugo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results